ENTRY       D12635                      Drug
NAME        Sozinibercept (USAN/INN)
FORMULA     C5398H8326N1448O1645S40
EXACT_MASS  121034.1198
MOL_WEIGHT  121109.1816
SEQUENCE    YSMTPPTLNI TEESHVIDTG DSLSISCRGQ HPLEWAWPGA QEAPATGDKD SEDTGVVRDC
            EGTDARPYCK VLLLHEVHAQ DTGSYVCYYK YIKARIEGTT AASSYVFVRD FEQPFINKPD
            TLLVNRKDAM WVPCLVSIPG LNVTLRSQSS VLWPDGQEVV WDDRRGMLVS TPLLHDALYL
            QCETTWGDQD FLSNPFLVHI TGNELYDIQL LPRKSLELLV GEKLVLNCTV WAEFNSGVTF
            DWDYPGKQAE RGKWVPERRS QQTHTELSSI LTIHNVSQHD LGSYVCKANN GIQRFRESTE
            VIVHEEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED
            PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA
            PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN
            YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Disulfide bridge: 27-87, 60-69, 134-182, 228-186, 310-310', 316-316', 319-319', 351-411, 457-515, 27'-87', 60'-69', 134'-182', 228'-286', 351'-411', 457'-515')
  TYPE      Peptide
EFFICACY    Angiogenesis inhibitor
COMMENT     Treatment of retinal diseases, including wet macular age-related macular degeneration
TARGET      VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
  PATHWAY   hsa04010(2324)  MAPK signaling pathway
            hsa04014(2324)  Ras signaling pathway
            hsa04015(2324)  Rap1 signaling pathway
            hsa04151(2324)  PI3K-Akt signaling pathway
            hsa04510(2324)  Focal adhesion
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               VEGFR family
                VEGFR3 (FLT4)
                 D12635  Sozinibercept (USAN/INN)
DBLINKS     CAS: 2568358-31-4
///
